PARDES BIOSCIENCES INC (PRDS) Stock Analyst Ratings
USA - NASDAQ:PRDS - US69945Q1058 - Common Stock
2.16 USD
0 (0%)
2.17 USD
+0.01 (+0.46%)
ChartMill assigns a Buy % Consensus number of 43% to PRDS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.27. This target is -40.97% below the current price.
PRDS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PRDS.
In the previous month the buy percentage consensus was at a similar level.
PRDS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-18 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-04-04 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2023-03-15 | JMP Securities | Maintains | Market Outperform |
| 2023-01-27 | SVB Leerink | Maintains | Outperform |
| 2022-12-13 | JMP Securities | Initiate | Market Outperform |
| 2022-08-16 | SVB Leerink | Maintains | Outperform |
| 2022-01-18 | Jefferies | Initiate | Buy |
PARDES BIOSCIENCES INC / PRDS FAQ
What do analysts expect the price target to be for PARDES BIOSCIENCES INC (PRDS)?
6 analysts have analysed PRDS and the average price target is 1.27 USD. This implies a price decrease of -40.97% is expected in the next year compared to the current price of 2.16.
How do analysts rate PARDES BIOSCIENCES INC (PRDS)?
The consensus rating for PARDES BIOSCIENCES INC (PRDS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.